| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 20.077 | 26.441 | 26.859 | 30.002 | 50.586 | 49.172 | 55.652 | 65.540 | 81.449 |
| Total Income - EUR | - | 20.077 | 26.947 | 26.859 | 30.003 | 50.591 | 49.424 | 57.712 | 65.540 | 81.449 |
| Total Expenses - EUR | - | 20.275 | 23.785 | 25.820 | 28.153 | 33.028 | 35.810 | 39.539 | 49.863 | 53.395 |
| Gross Profit/Loss - EUR | - | -199 | 3.161 | 1.039 | 1.850 | 17.564 | 13.615 | 18.174 | 15.677 | 28.054 |
| Net Profit/Loss - EUR | - | -801 | 1.628 | 233 | 950 | 16.104 | 12.310 | 16.903 | 15.120 | 25.736 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Uroimage Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 17 | 20.270 | 17.372 | 17.869 | 45.730 | 35.937 | 61.626 | 50.504 | 35.383 |
| Current Assets | - | 5.104 | 3.375 | 7.668 | 26.580 | 23.381 | 18.672 | 19.471 | 27.990 | 9.743 |
| Inventories | - | 35 | 0 | 0 | 0 | 1.654 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.759 | 1.187 | 3.935 | 6.834 | 9.090 | 7.376 | 6.250 | 11.814 | 7.486 |
| Cash | - | 3.310 | 2.188 | 3.733 | 19.746 | 12.636 | 11.296 | 13.222 | 16.176 | 2.257 |
| Shareholders Funds | - | -756 | 884 | 1.101 | 2.030 | 18.095 | 30.004 | 47.000 | 61.977 | 36.719 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 5.877 | 22.761 | 23.938 | 42.419 | 51.015 | 24.606 | 34.098 | 16.516 | 8.407 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Uroimage Med Srl